The need for analytical technology that reveals the effect of production process on CQAs of viral particles in gene therapy and vaccines, and the most common analyses requested.
Contact
Vironova AB
Gävlegatan 22
113 30 Stockholm
SWEDEN
E-mail: info@vironova.com